Stock UniverseDerived research view · source repositories remain read-only

Immatics N.V. (IMTX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
37.33
Global Rank
841
Market Cap
1.39B
Latest Close
9.79
RS Composite
-10.89% · G#2150

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-14.94%
3M
-0.71%
6M
-5.32%
1Y
70.26%
3Y
-0.81%
5Y
-12.82%
10Y
1.98%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.03M · 30-day average: 588.14K · Max drawdown over stored range: -79.41%

Research Snapshot

Relative Strength vs SPX

RS Composite-10.89%
20D RS-12.75%
60D RS-11.37%
120D RS-9.49%
Global RS Rank2150 · 35.92% percentile
Qualified+ RS Rank809 · 35.69% percentile
Group ScopeQualified+
Primary RS Rank209 · 54.37% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank152 / 701
Primary Percentile78.46
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for IMTX.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue31.25334.763172.83153.997155.83548.266
Revenue Growth (YoY)69.402%11.231%397.169%-68.757%188.599%-69.027%
Gross Profit-35.832-52.81166.052-64.6667.756-135.566
Operating Income-69.715-86.29429.954-101.725-38.615-182.016
Free Cash Flow-88.116-89.85294.393-12.571-174.302-183.184
Free Cash Flow Per Share-1.836-1.4281.371-0.156-1.632-1.497
EPS (Diluted) GAAP-4.401637-1.4835580.399999-1.180.14-1.61
EPS Growth
EPS Non-GAAP
Gross Margin-114.651%-151.917%38.218%-119.758%4.977%-280.873%
Operating Margin-223.067%-248.235%17.331%-188.39%-24.779%-377.11%
Profit Margin-676.044%-268.489%16.029%-175.286%9.765%-407.009%
Free Cash Flow Margin-281.944%-258.47%54.616%-23.281%-111.85%-379.53%
Shares Outstanding (Diluted)48.001262.912968.824980.5467106.7951122.3484
Shares Change (YoY)45.046%31.065%9.397%17.031%32.588%14.564%

SEC Quarterly Fundamentals

No processed quarterly rows for IMTX.